ES527763A0 - Un procedimiento para la preparacion de un derivado de cefalosporina - Google Patents

Un procedimiento para la preparacion de un derivado de cefalosporina

Info

Publication number
ES527763A0
ES527763A0 ES527763A ES527763A ES527763A0 ES 527763 A0 ES527763 A0 ES 527763A0 ES 527763 A ES527763 A ES 527763A ES 527763 A ES527763 A ES 527763A ES 527763 A0 ES527763 A0 ES 527763A0
Authority
ES
Spain
Prior art keywords
procedure
preparation
cephalosporin derivative
cephalosporin
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES527763A
Other languages
English (en)
Other versions
ES8505374A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES527763A0 publication Critical patent/ES527763A0/es
Publication of ES8505374A1 publication Critical patent/ES8505374A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/46Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ES527763A 1981-09-08 1983-12-02 Un procedimiento para la preparacion de un derivado de cefalosporina Expired ES8505374A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30035781A 1981-09-08 1981-09-08
US34062882A 1982-01-19 1982-01-19

Publications (2)

Publication Number Publication Date
ES527763A0 true ES527763A0 (es) 1985-05-16
ES8505374A1 ES8505374A1 (es) 1985-05-16

Family

ID=26971737

Family Applications (2)

Application Number Title Priority Date Filing Date
ES515548A Expired ES8404361A1 (es) 1981-09-08 1982-09-07 Un procedimiento para la preparacion de un derivado de cefalosporina.
ES527763A Expired ES8505374A1 (es) 1981-09-08 1983-12-02 Un procedimiento para la preparacion de un derivado de cefalosporina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES515548A Expired ES8404361A1 (es) 1981-09-08 1982-09-07 Un procedimiento para la preparacion de un derivado de cefalosporina.

Country Status (17)

Country Link
EP (1) EP0074268A3 (es)
KR (1) KR840001585A (es)
CS (1) CS232735B2 (es)
DD (1) DD209633A5 (es)
DK (1) DK399282A (es)
ES (2) ES8404361A1 (es)
FI (1) FI823088L (es)
GB (1) GB2105719A (es)
GR (1) GR76701B (es)
HU (1) HU187575B (es)
IL (1) IL66726A0 (es)
NZ (1) NZ201833A (es)
PH (1) PH19756A (es)
PL (1) PL238158A1 (es)
PT (1) PT75518B (es)
RO (1) RO84456B (es)
SU (1) SU1169542A3 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5910593A (ja) * 1982-06-28 1984-01-20 Bristol Mayers Kenkyusho Kk セフアロスポリン誘導体
US4480098A (en) * 1982-11-12 1984-10-30 Eli Lilly And Company Preparation of alkali metal thieno(furo)pyridines
US4525473A (en) * 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins
EP0137442A3 (de) * 1983-10-08 1986-01-15 Hoechst Aktiengesellschaft Cephalosporinderivate und Verfahren zu ihrer Herstellung
EP0138552A3 (en) * 1983-10-17 1986-03-19 Eli Lilly And Company Improvements on or relating to 3-bicyclicpyridinium-methyl cephalosporins
US4868173A (en) * 1984-11-20 1989-09-19 Ici Pharma Cephalosporin derivatives
EP0187456A1 (en) * 1984-11-29 1986-07-16 Ici Pharma Cephalosporin derivatives
ATE89826T1 (de) * 1985-03-01 1993-06-15 Takeda Chemical Industries Ltd Antibakterielle verbindungen, ihre herstellung und verwendung.
US4703118A (en) * 1985-04-08 1987-10-27 Eli Lilly And Company Synthesis of 3-iodomethyl cephalosporins
US4714760A (en) * 1985-08-20 1987-12-22 Bristol-Myers Company Cephalosporin intermediates
GB8626245D0 (en) * 1985-11-27 1986-12-03 Ici Pharma Cephalosporin compounds
US4868294A (en) * 1986-07-11 1989-09-19 Bristol-Myers Company Process for preparing cephalosporin intermediates
US4918067A (en) * 1986-07-24 1990-04-17 Beecham Group P.L.C. Heterocyclic substituted penicillin antibiotics
TW526202B (en) 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
CA2395648A1 (en) * 2000-02-10 2001-08-16 Pharmacia & Upjohn Company Oxazolidinone thioamides with piperazine amide substituents
US6642238B2 (en) 2000-02-10 2003-11-04 Pharmacia And Upjohn Company Oxazolidinone thioamides with piperazine amide substituents
US7847093B2 (en) 2003-04-16 2010-12-07 Sandoz Ag Processes for the preparations of cefepime
EP1618114B1 (en) 2003-04-16 2010-07-14 Sandoz AG Processes for the preparations of cefepime

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
GR63088B (en) * 1976-04-14 1979-08-09 Takeda Chemical Industries Ltd Preparation process of novel cephalosporins
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
FR2440738A1 (fr) * 1978-11-13 1980-06-06 Parcor Medicament a base de derives des thieno (2,3-c) et (3,2-c) pyridines
DE3118732A1 (de) * 1981-05-12 1982-12-02 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
DE3207840A1 (de) * 1982-03-04 1983-09-15 Hoechst Ag, 6230 Frankfurt "cephalosporinderivate und verfahren zu ihrer herstellung"

Also Published As

Publication number Publication date
PT75518B (en) 1985-11-12
FI823088L (fi) 1983-03-09
DK399282A (da) 1983-03-09
EP0074268A2 (en) 1983-03-16
GR76701B (es) 1984-08-29
IL66726A0 (en) 1982-12-31
PT75518A (en) 1982-10-01
GB2105719A (en) 1983-03-30
RO84456A (ro) 1984-06-21
ES515548A0 (es) 1984-04-16
PH19756A (en) 1986-06-26
RO84456B (ro) 1984-08-30
HU187575B (en) 1986-01-28
EP0074268A3 (en) 1984-05-23
SU1169542A3 (ru) 1985-07-23
ES8505374A1 (es) 1985-05-16
NZ201833A (en) 1985-09-13
PL238158A1 (en) 1984-11-19
CS650582A2 (en) 1984-06-18
ES8404361A1 (es) 1984-04-16
KR840001585A (ko) 1984-05-07
CS232735B2 (en) 1985-02-14
DD209633A5 (de) 1984-05-16
FI823088A0 (fi) 1982-09-07

Similar Documents

Publication Publication Date Title
ES505517A0 (es) Un procedimiento para la preparacion de un derivado de n- arilbenzamida
ES530714A0 (es) Un procedimiento para la preparacion de un derivado de carbostirilo
ES548672A0 (es) Un procedimiento para la preparacion de un derivado de dihi-dropiridina
ES514993A0 (es) Un procedimiento para la preparacion de nuevos derivados de cefalosporina.
ES505950A0 (es) Un procedimiento para la preparacion de un derivado de tia- zol
ES505678A0 (es) Un procedimiento para la preparacion de un derivado de 3- aril-5-isotiazol
ES527661A0 (es) Un procedimiento para la preparacion de nuevos derivados de cefalosporina.
ES510307A0 (es) Un procedimiento para la preparacion de un compuesto de cefalosporina.
ES529349A0 (es) Un procedimiento para la preparacion de derivados de acilmorfinano
ES557051A0 (es) Un procedimiento para la preparacion de derivados de cefalosporina
ES527763A0 (es) Un procedimiento para la preparacion de un derivado de cefalosporina
ES524922A0 (es) Un procedimiento para la preparacion de nuevos derivados de 3-amino-pregn-5-eno
ES556786A0 (es) Un procedimiento para la preparacion de derivados de cefalosporina
ES551551A0 (es) Un procedimiento para la preparacion de nuevos derivados de cefalosporina
MX158194A (es) Procedimiento para la preparacion del sesquihidrato de un derivado de naftiridina
ES524399A0 (es) Un procedimiento para la preparacion de derivados de milbenicina d
ES526397A0 (es) Un procedimiento para la preparacion de nuevos derivados de cefalosporina
ES536982A0 (es) Un procedimiento para la preparacion de un derivado de carbostirilo
ES504764A0 (es) Un procedimiento para la preparacion de un derivado 2-tiope-nem
ES506142A0 (es) Un procedimiento para la preparacion de nuevos acilderivadosde cefalosporina
ES504376A0 (es) Un procedimiento para la preparacion de un derivado de fene-tilamina
ES518347A0 (es) Un procedimiento para la preparacion de derivados de desoxiuridina
ES515988A0 (es) Un procedimiento para la preparacion de nuevos derivados bencilicos trisustituidos
ES526149A0 (es) Un procedimiento para la preparacion de derivados de espirotiazolidinil-piperazina
ES541840A0 (es) Un procedimiento para la preparacion de un derivado de imi- dazolilo